Depistage neonatal de la mucoviscidose : vers une implementation nationale en Belgique en 2019.

BOBOLI, Hedwige; BOEMER, François; MASTOURI, Meriem; Seghaye, Marie-Christine

Download

Article (Scientific journals)

Depistage neonatal de la mucoviscidose : vers une implementation nationale en Belgique en 2019.

BOBOLI, Hedwige; BOEMER, François; MASTOURI, Meriem et al.

2018 • In Revue Médicale de Liège, 73 (10), p. 497-501

Peer reviewed

Permalink
https://hdl.handle.net/2268/232328

PubMed
30335254

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Dépistage néonatal de la mucoviscidose.pdf

Publisher postprint (273.3 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Belgium; Newborn screening; Cystic fibrosis

Abstract :

[en] Cystic fibrosis has in Belgium a prevalence of 1/2.850 births, with a median age at diagnosis of 7 months according to the latest data from the Belgian registry of 2015. In our country, the diagnosis of cystic fibrosis is always based on signs and symptoms of the disease. However, because the scientific literature has largely demonstrated the benefits of neonatal screening for cystic fibrosis, it will be implemented in Belgium before the end of 2019. The screening programme should be framed by strict quality criteria in order to obtain the best performance with the least possible inconvenience.

Disciplines :

Pediatrics
Cardiovascular & respiratory systems

Author, co-author :

BOBOLI, Hedwige ; Centre Hospitalier Universitaire de Liège - CHU > Département de Pédiatrie > Service de pédiatrie

BOEMER, François ; Centre Hospitalier Universitaire de Liège - CHU > Unilab > Laboratoire Biochimie Génétique

MASTOURI, Meriem ; Centre Hospitalier Universitaire de Liège - CHU > Département de Pédiatrie > Service de pédiatrie

Seghaye, Marie-Christine ; Université de Liège - ULiège > Département des sciences cliniques > Pédiatrie cardiologique et pneumologique

Language :

French

Title :

Depistage neonatal de la mucoviscidose : vers une implementation nationale en Belgique en 2019.

Alternative titles :

[en] Neonatal screening for cystic fibrosis : towards a national implementation in Belgium in 2019

Publication date :

October 2018

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

497-501

Peer reviewed :

Peer reviewed

Available on ORBi :

since 30 January 2019

Statistics

Number of views

245 (8 by ULiège)

Number of downloads

416 (9 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Registre Belge de la Mucoviscidose.- Annual report. Belgian Cystic Fibrosis Registry, 2015.
Sims EJ, Clark A, McCormick J, et al.- Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatr, 2007, 119, 19-28.
Chatfield S, Owen G, Ryley HC, et al.- Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening. Arch Dis Child, 1991, 66, 29-33.
Farrell PM, Kosorok MR, Laxova A, et al.- Nutritional benefits of neonatal screening for cystic fibrosis. N Engl J Med, 1997, 337, 963-969.
Merelle ME, Nagelkerke AF, Lees CM, et al.- Newborn screening for cystic fibrosis. Cochrane Database Syst Rev, 2001, CD001402.
Koscik RL, Lai HJ, Laxova A, et al.- Preventing early, prolonged vitamine E deficiency: an opportunity for better cognitive outcomes via early diagnosis through NBS. J Pediatr, 2005, 147, S51-S56.
Zemel BS, Jawad AF, FitzSimmons S, et al.- Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr, 2000, 137, 374-380.
Konstan MW, Butler SM, Wohl ME, et al.- Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr, 2003, 142, 624-630.
Baussano I, Tardivo I, Bellezza-Fontana R, et al.-Neonatal screening for CF does not affect time to first infection with Pseudomonas aeruginosa. Pediatrics, 2006, 118, 888-895.
Wang SS, FitzSimmons SC, O'Leary LA, et al.-Early diagnosis of CF in the newborn period and risk of Pa acquisition in the first 10 years of life: A registry-based longitudinal study. Pediatrics, 2001, 107, 274-279.
McKay KO, Waters DL, Gaskin KJ.- The influence of newborn screening for cystic fibrosis on pulmonary outcomes in New South Wales. J Pediatr, 2005, 147, S47-S50.
Siret D, Bretaudeau G, Branger B, et al.- Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany). Pediatr Pulmonol, 2003, 35, 324-329.
Sims EJ, McCormick J, Mehta G, et al.- Neonatal screening for cystic fibrosis is beneficial even in the context of modern treatment. J Pediatr, 2005, 147, S42-S46.
Lai HJ, Cheng Y, Farrell PM.- The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data. J Pediatr, 2005, 147, S57-S63.
Doull IJ, Ryley HC, Weller P, et al.- Cystic fibrosis-related deaths in infancy and the effect of newborn screening. Pediatr Pulmonol, 2001, 31, 363-366.
Dijk FN, McKay K, Barzi F, et al.- Improved survival in CF patients diagnosed by newborn screening compared to a historical cohort from the same centre. Arch Dis Child, 2011, 96, 1118-1123.
Grosse Sd, Rosenfeld M, Devine OJ, et al.- Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. J Pediatr, 2006, 149, 362-366.
Accurso FJ, Sontag MK, Wagener JS.- Complications associated with symptomatic diagnosis in infants with cystic fibrosis. J Pediatr, 2005, 147, S37-S41.
Koscik RL, Douglas JA, Zaremba K, et al.- Quality of life of children with cystic fibrosis. J Pediatr, 2005, 147, S64-S68.
Mérelle ME, Huisman J, Alderden-van der Vecht A, et al.- Early versus late diagnosis: psychological impact on parents of children with cystic fibrosis. Pediatrics, 2003, 111, 346-350.
Parsons EP, Bradley DM.- Psychosocial issues in newborn screening for cystic fibrosis. Paediatr Res-pir Rev, 2003, 4, 285-292.
Dudding T, Wilcken B, Burgess B, et al.- Reproductive decisions after neonatal screening identifies cystic fibrosis. Arch Dis Child, Fetal Neonatal Ed. 2000, 82, F124-F127.
Lee DS, Rosenberg MA, Peterson A, et al.- Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program. J Pediatr, 2003, 142, 617-623.
Sims EJ, Mugford M, Clark A, et al.- Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study. Lancet, 2007, 369, 1187-1195.
Faut-il un dépistage néonatal de la mucoviscidose en Belgique ? KCE reports, 132B, 2010.
Munck A, Roussey M.- The French nationwide cystic fibrosis newborn screening program: strategy and results. Arch Ped, 2008, 15, S1-S6.